Literature DB >> 28687579

Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era.

Ling-Long Tang, Yu-Pei Chen, Yan-Ping Mao, Zi-Xian Wang, Rui Guo, Lei Chen, Li Tian, Ai-Hua Lin, Li Li, Ying Sun, Jun Ma.   

Abstract

Background: In this study, we evaluated the 8th edition of the Union for International Cancer Control (UICC)/AJCC staging system for nasopharyngeal carcinoma (NPC) in an endemic area, with the aim of validating its applicability and providing further information for future refinements.
Methods: A total of 1,790 patients with newly diagnosed, non-distant metastatic, histologically proven NPC treated with intensity-modulated radiotherapy (IMRT) were retrospectively reviewed. The performance of various staging systems was compared using the Akaike information criterion (AIC) and Harrell's concordance index (c-index).
Results: For N (node) category, the survival curves of different groups according to the 8th edition were well-separated, and the prognostic model predicted outcomes fairly well. The 8th edition had higher AIC and c-index values for all end points than the 7th edition. However, probably due to the improved locoregional control provided by IMRT, the survival curves for T2 and T3 almost overlapped, without significant differences in locoregional failure-free survival (P=.606) and disease-free survival (P=.735). Due to the difficultly of differentiating T2 and T3, the AIC and c-index values were similar for the T categories of the 7th and 8th editions. Similarly, the overall survival and disease-free survival curves for stage II and III disease were not clearly separated for either the 8th or 7th editions. Conclusions: The 8th edition of the UICC/AJCC staging system for NPC enables more accurate prediction of treatment outcomes. However, several limitations need to be addressed in future editions, and it would be reasonable to further optimize the T category classification.
Copyright © 2017 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2017        PMID: 28687579     DOI: 10.6004/jnccn.2017.0121

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  37 in total

Review 1.  The evolution of nasopharyngeal carcinoma staging.

Authors:  Rui Guo; Yan-Ping Mao; Ling-Long Tang; Lei Chen; Ying Sun; Jun Ma
Journal:  Br J Radiol       Date:  2019-07-12       Impact factor: 3.039

2.  Nodal grouping in nasopharyngeal carcinoma: prognostic significance, N classification, and a marker for the identification of candidates for induction chemotherapy.

Authors:  Yifei Liu; Shenghuan Chen; Annan Dong; Fei Ai; Tingting Quan; Chunyan Cui; Jian Zhou; Shaobo Liang; Jiamin Wang; Shunxin Wang; Ling Hua; Shuoyu Xu; Mingyuan Chen; Ying Sun; Haojiang Li; Lizhi Liu
Journal:  Eur Radiol       Date:  2019-12-06       Impact factor: 5.315

3.  Radiomics on multi-modalities MR sequences can subtype patients with non-metastatic nasopharyngeal carcinoma (NPC) into distinct survival subgroups.

Authors:  En-Hong Zhuo; Wei-Jing Zhang; Hao-Jiang Li; Guo-Yi Zhang; Bing-Zhong Jing; Jian Zhou; Chun-Yan Cui; Ming-Yuan Chen; Ying Sun; Li-Zhi Liu; Hong-Min Cai
Journal:  Eur Radiol       Date:  2019-03-14       Impact factor: 5.315

4.  Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.

Authors:  Cheng-Long Huang; Rui Guo; Jun-Yan Li; Cheng Xu; Yan-Ping Mao; Li Tian; Ai-Hua Lin; Ying Sun; Jun Ma; Ling-Long Tang
Journal:  Eur Radiol       Date:  2019-10-24       Impact factor: 5.315

5.  Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: Clinical implications for treatment strategies and surveillance.

Authors:  Jingbo Wang; Xiaodong Huang; Shiran Sun; Kai Wang; Yuan Qu; Xuesong Chen; Runye Wu; Ye Zhang; Qingfeng Liu; Jianghu Zhang; Jingwei Luo; Jianping Xiao; Li Gao; Guozhen Xu; Chen Hu; Ye-Xiong Li; Junlin Yi
Journal:  Cancer Med       Date:  2021-05-06       Impact factor: 4.452

6.  MRI-based radiomics as response predictor to radiochemotherapy for metastatic cervical lymph node in nasopharyngeal carcinoma.

Authors:  Hao Xu; Jieke Liu; Ying Huang; Peng Zhou; Jing Ren
Journal:  Br J Radiol       Date:  2021-04-21       Impact factor: 3.629

7.  The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up.

Authors:  San-Gang Wu; Chen-Lu Lian; Jun Wang; Wen-Wen Zhang; Jia-Yuan Sun; Qin Lin; Zhen-Yu He
Journal:  Ann Transl Med       Date:  2019-12

8.  Epstein-Barr virus nuclear antigen-1 is useful as therapeutic efficacy marker in serum but not in saliva of nasopharyngeal cancer patients who underwent radiotherapy.

Authors:  Yurnadi H Midoen; Dwi A Suryandari; Luluk Yunaini; Raden Susworo; Elza I Auerkari; Hans-Joachim Freisleben
Journal:  Ecancermedicalscience       Date:  2021-06-21

9.  Sequential induction chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: the three-year report of a phase II, single center, randomized, non-inferiority trial.

Authors:  Zhining Yang; Zeman Cai; Qingxin Cai; Yingji Hong; Cuidai Zhang; Kaichun Huang; Zhixiong Lin; Mei Li
Journal:  Cancer Med       Date:  2021-05-06       Impact factor: 4.452

10.  Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area.

Authors:  Ji-Jin Yao; Li Lin; Tian-Sheng Gao; Wang-Jian Zhang; Wayne R Lawrence; Jun Ma; Ying Sun
Journal:  Cancer Res Treat       Date:  2020-12-07       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.